Marpai is a technology-enabled third-party administrator (TPA) that provides claims administration, network access, clinical and care management partnerships, an in-house PBM (MarpaiRx), and member-facing portals and a mobile app to support self-funded, employer-sponsored health plans.
Published Sep 29, 2026
Not explicitly stated; however, Marpai’s size relative to major national TPAs suggests buyers should validate:
Direct employer churn narratives are not widely published. However, complaint and employee-review data suggest potential churn drivers:
The myMarpai iOS app is poorly rated on the Apple App Store. App store ratings are a small sample and may be volatile, but they can indicate friction with account setup, performance, or usefulness.
Employee reviews present mixed-to-negative sentiment on Glassdoor and Indeed. Themes cited in commentary include strategic shifts, leadership and management concerns, operational stress, and execution challenges. These signals can correlate with operational consistency experienced by plan sponsors and members.
Based on Marpai’s product messaging and typical TPA buyer priorities, likely reasons include:
Marpai’s marketing includes vendor-reported savings figures and repricing claims. These claims are not accompanied by transparent methodologies, sample sizes, or third-party audits in the public materials reviewed. Buyers should request:
Based on Marpai’s public positioning:
Not explicitly specified publicly. Self-funded adoption is commonly seen in:
Get a comprehensive analysis of Marpai including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Consider alternatives or proceed with caution when:
Sources supporting caution signals:
Sources:
Marpai announced a collaboration with Empara to roll out a unified member engagement platform, with vendor statements expecting the platform to be live by end of Q2 2025.
Critical note: This is a vendor press-release timeline; buyers should confirm actual delivery and current platform capabilities.
Source:
Sources:
Source:
Sources:
Marpai is not a typical SaaS tool where G2/Capterra reviews are common and plentiful. For a TPA, many users are employees/members interacting through claims and portals, and feedback often appears through:
During research, no clearly attributable Marpai product listing with a meaningful volume of reviews was found on mainstream B2B review sites.
Public complaints include recurring themes:
Analyst note: Marpai’s public responses to complaints often emphasize the administrative role and allocation of responsibility between administrator and plan sponsor. While this is common for TPAs, it can be perceived by members as a lack of direct resolution.
Marpai has announced partnerships with value-based care providers and reports using analytics to identify and enroll members for interventions intended to reduce high-cost utilization.
Musculoskeletal partnership: The vendor describes a collaboration with a musculoskeletal care provider and cites third-party validation for certain care protocols and reductions in high-intensity interventions.
Digestive health partnership: The vendor reports cost and outcome improvements from a virtual digestive health program.
Marpai is a third-party administrator (TPA) and related services platform for employer-sponsored, self-funded health plans. In practice, Marpai positions itself as a technology-enabled TPA that combines:
Marpai states objectives to reduce employer health plan costs and to improve member experience and outcomes, including outreach to at-risk members using analytics and machine learning. These are vendor-reported objectives; independent validation of claimed outcomes is limited in publicly available materials.